Recall events
/
Event 89717
Event summary
Timeline bucket March 08, 2022
Product types Drug
Classifications Class II and Class III
Statuses Terminated
Recalling firm wording Olympia Compounding Pharmacy dba Olympia Pharmacy
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
7 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 7
Sermorelin Acetate Lyophilized powder for reconstitution, Multi-Dose 9 mg per vial, Each ML contains: 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0059-00
D-0718-2022
Recall number D-0718-2022
Initiated March 08, 2022
Classification Class II
Status Terminated
Quantity 2283 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Sub Potent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Sub Potent
Code information Lots: D44026 Exp. 4/26/22; F42104 Exp. 6/4/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13216]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 7
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00
D-0719-2022
Recall number D-0719-2022
Initiated March 08, 2022
Classification Class II
Status Terminated
Quantity 2634 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Product found to be Sub Potent or Exceeded reconstitution time
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Product found to be Sub Potent or Exceeded reconstitution time
Code information Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12672]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 7
Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01 mg/mL, Multi-Dose 10 mL vial, Each ML contains: 0.5% Chlorobutanol NF, 0.005% Edetate Disodium Dihydrate USP, 2.74% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 1% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0004-10
D-0720-2022
Recall number D-0720-2022
Initiated March 08, 2022
Classification Class III
Status Terminated
Quantity 493 vials.
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Sub Potent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Sub Potent
Code information Lot: D41C19 Exp. 4/19/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12957]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 7
T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL packaged as a) 5 mL Multi-dose NDC 73198-0005-05; b) 10 mL Multi-dose NDC 73198-0005-10; Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 0.5% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.
D-0721-2022
Recall number D-0721-2022
Initiated March 08, 2022
Classification Class III
Status Terminated
Quantity 1093 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Super Potent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Super Potent
Code information Lots: a) E41F10 Exp. 5/10/22; b) E41G10 Exp. 5/10/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12965]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 7
SB-4, Papaverine 30mg/mL, Phentolamine 3mg/mL, Alprostadil 40mcg/mL, packaged in a) 5 mL Multi-dose vial NDC 73198-0023-05; b) 10 mL Multi-dose vial NDC 73198-0023-10, Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 2% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, Conroy Rd., Ste. 155, Orlando, FL 32835
D-0722-2022
Recall number D-0722-2022
Initiated March 08, 2022
Classification Class III
Status Terminated
Quantity 1032 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Sub Potent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Sub Potent
Code information Lots: a) E41C18 Exp. 5/18/22; b) E41D18 Exp. 5/18/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12490]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 7
Hydroxocobalamin B12 1mg/mL, Multi-Dose 30 mL vial, Each ML contains: 0.82% Sodium Chloride USP, 0.9% Benzyl Alcohol NF, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals Conroy Rd., Ste. 155, Orlando, FL 32835 NDC 73198-0080-30
D-0723-2022
Recall number D-0723-2022
Initiated March 08, 2022
Classification Class III
Status Terminated
Quantity 1613 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Sub Potent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Sub Potent
Code information Lot: E47025 Exp. 5/21/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12480]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 7
Sincalide Lyophilized powder for reconstitution Each ML contains: Mannitol 170mg, Arginine 30mg, Lysine 15mg, Potassium Phosphate 9mg, Methionine 4mg, Edetate Disodium Dihydrate 2mg, Polysorbate mcg, Water for Injection, Multiple Dose Injection 5 mcg Vial, Rx Only, Olympia Compounding Pharmacy Compounded by: Olympia Pharmacy Conroy Rd., Ste. 155, Orlando, FL 32835, NDC 73198-0082-00 Revised Label: Sincalide Lyophilized powder for reconstitution, 5mcg per multi dose vial, Each ML contains: 16.7% Mannitol, 3% Arginine, 1.5% Lysine, 0.9% Potassium Phosphate, 0.4% Methionine, 0.2% Edetate Disodium Dihydrate, 0.004% Sodium Metabisulfate, 0.0005% Polysorbate. Water for injection. Rx only, Olympia Pharmaceuticals NDC 73198-0082-00
D-0724-2022
Recall number D-0724-2022
Initiated March 08, 2022
Classification Class II
Status Terminated
Quantity 836 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Super Potent and Failed Reconstitution Time
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Super Potent and Failed Reconstitution Time
Code information Lot: D24001 Exp. 4/1/22
Distribution pattern Nationwide in the USA including Puerto Rico.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12955]
FDA event record
· Exact recall-number query on openFDA
